HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Afshin Samali Selected Research

Nerve Growth Factor Receptors (Neurotrophin Receptors)

1/2018Generation of rationally-designed nerve growth factor (NGF) variants with receptor specificity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Afshin Samali Research Topics

Disease

23Neoplasms (Cancer)
09/2021 - 06/2006
9Necrosis
07/2016 - 12/2003
8Glioblastoma (Glioblastoma Multiforme)
04/2024 - 01/2018
7Hypoxia (Hypoxemia)
01/2021 - 12/2003
5Breast Neoplasms (Breast Cancer)
01/2020 - 01/2018
5Ischemia
01/2014 - 12/2003
4Parkinson Disease (Parkinson's Disease)
03/2023 - 12/2003
3Triple Negative Breast Neoplasms
01/2022 - 01/2018
3Inflammation (Inflammations)
12/2019 - 11/2013
2Disease Progression
01/2021 - 01/2019
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021 - 01/2015
2Carcinoma (Carcinomatosis)
09/2011 - 04/2010
1Renal Cell Carcinoma (Grawitz Tumor)
11/2022
1Neoplasm Metastasis (Metastasis)
09/2021
1Idiopathic Pulmonary Fibrosis
01/2021
1Sarcoma (Soft Tissue Sarcoma)
10/2020
1Rhabdomyosarcoma
10/2020
1Mast-Cell Leukemia (Leukemia, Mast Cell)
01/2019
1Fibrosis (Cirrhosis)
01/2018
1Chronic Pain
01/2018
1Brain Neoplasms (Brain Tumor)
01/2018
1Infections
12/2015
1Philadelphia Chromosome
01/2015
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2015
1Hyperglycemia
01/2014
1Heart Diseases (Heart Disease)
01/2014
1Cardiovascular Diseases (Cardiovascular Disease)
01/2014
1Acidosis
01/2014
1Starvation
10/2013
1Virus Diseases (Viral Diseases)
10/2013
1Multiple Myeloma
06/2013
1Shock
12/2012
1Hypersensitivity (Allergy)
11/2012
1Neuroinflammatory Diseases
10/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2011
1Mitochondrial Diseases (Mitochondrial Disease)
10/2011

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
09/2021 - 05/2009
9LigandsIBA
01/2020 - 06/2006
6Death Domain ReceptorsIBA
11/2013 - 06/2006
6CaspasesIBA
11/2013 - 12/2003
4Temozolomide (Temodar)FDA LinkGeneric
04/2024 - 01/2018
4Ribonucleases (Ribonuclease)IBA
02/2023 - 01/2018
4Oxygen (Dioxygen)IBA
11/2022 - 11/2006
4Glucose (Dextrose)FDA LinkGeneric
01/2014 - 11/2006
3TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
05/2009 - 06/2006
2Simvastatin (Zocor)FDA LinkGeneric
04/2024 - 10/2020
2CytokinesIBA
01/2021 - 05/2009
2Inositol (Myoinositol)IBA
01/2021 - 10/2018
2EnzymesIBA
01/2021 - 10/2018
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 03/2009
2Protein Kinases (Protein Kinase)IBA
12/2019 - 11/2013
2Paclitaxel (Taxol)FDA LinkGeneric
01/2019 - 01/2018
2Nerve Growth Factor (NGF)IBA
01/2018 - 12/2006
2AntibodiesIBA
12/2015 - 05/2009
2Caspase 3 (Caspase-3)IBA
12/2015 - 03/2009
2MicroRNAs (MicroRNA)IBA
01/2014 - 01/2013
2Small Interfering RNA (siRNA)IBA
11/2012 - 07/2006
2Antineoplastic Agents (Antineoplastics)IBA
03/2009 - 07/2008
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2008 - 06/2006
2Dexamethasone (Maxidex)FDA LinkGeneric
05/2007 - 07/2006
2Oxidopamine (6 Hydroxydopamine)IBA
12/2006 - 02/2005
2NeurotoxinsIBA
02/2005 - 12/2003
1Biomarkers (Surrogate Marker)IBA
03/2023
1Triglycerides (Triacylglycerol)IBA
01/2022
1MKC8866IBA
12/2020
1Benzoates (Benzoate)IBA
01/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2020
1OxalatesIBA
01/2020
1hydroxide ionIBA
01/2020
11,2-cyclohexanediamine (dach)IBA
01/2020
1Acute-Phase Proteins (Acute-Phase Protein)IBA
12/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2019
1Protein Isoforms (Isoforms)IBA
01/2019
1KIRA6IBA
01/2019
17- methyl- 5- (1- ((3- (trifluoromethyl)phenyl)acetyl)- 2,3- dihydro- 1H- indol- 5- yl)- 7H- pyrrolo(2,3- d)pyrimidin- 4- amineIBA
01/2019
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2018
1CollagenIBA
01/2018
1Alkylating AgentsIBA
01/2018
1Fibronectins (Fibronectin)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2016
1Endoplasmic Reticulum Chaperone BiPIBA
12/2015
1Phosphotransferases (Kinase)IBA
01/2015
1CalciumIBA
01/2014
1Amino AcidsFDA Link
11/2013
1MitogensIBA
11/2013
1Nerve Growth Factors (Neurotrophins)IBA
11/2013
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2013
1Type I Tumor Necrosis Factor ReceptorsIBA
11/2013
1TNF-Related Apoptosis-Inducing LigandIBA
11/2013
1Ectodysplasin ReceptorsIBA
11/2013
1Serine (L-Serine)FDA Link
10/2013
1Proteasome InhibitorsIBA
06/2013
1ProteomeIBA
12/2012
1Free RadicalsIBA
10/2011
1Glutamic Acid (Glutamate)FDA Link
10/2011
1fucoidanIBA
09/2011

Therapy/Procedure

15Therapeutics
09/2021 - 06/2006
6Drug Therapy (Chemotherapy)
01/2021 - 01/2018